Medovex
2013
FOUNDED
PUBLIC
STATUS
1-10
EMPLOYEES
HCYT
STOCK SYMBOL
2
INVESTMENTS
$0.14
SHARE PRICE
(As of Friday Closing)
Description
H-CYTE Inc engages in the design and marketing of proprietary medical devices. It operates its business under two brands including Lung Health Institute, and DenerveX System. Lung Health Institute is a provider of regenerative medicine and provides an approach to addressing chronic lung disease. The DenerveX system is designed to treat facet joints. It uses Rotacapsulation to deliver high heat and capsular tissue shaving in a posterior capsulectomy procedure that treats the posterior synovial capsule, targets the facet joint nerve receptors, and terminates the nerve.
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
PINX
Primary Office
- 3060 Royal Boulevard South
- Suite 150
- Alpharetta, GA 30022
- United States
+1 (404) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Medovex’s full profile, request a free trial.
Medovex Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.06 - $0.65 | $14.4M | $0.12 | -$0.18 | 68K | 99M |
Medovex Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 13,999 | 10,123 | 10,113 | 20,713 |
| Revenue | 6,718 | 818 | 207 | 0 |
| EBITDA | (11,819) | (4,723) | (6,033) | (12,657) |
| Net Income | (12,802) | (4,909) | (6,456) | (16,227) |
| Total Assets | 17,580 | 404 | 1,228 | 1,508 |
| Total Debt | 2,997 | 697 | 171 | 1,200 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Medovex Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Medovex‘s full profile, request access.
Request full access to PitchBookMedovex Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 00000 | 14-Jan-2019 | 000000000 00000 00 | Buildings and Property | 0000000 00000 | |
| Streamline (Healthcare) | 26-Mar-2015 | Merger/Acquisition | 00.00 | Other Healthcare Technology Systems | 0000000 000000 |
Medovex Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Medovex‘s full profile, request access.
Request full access to PitchBookMedovex Executive Team (7)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| William Horne | Chief Executive Officer & Chairman | ||
| Charlie Farrahar | Chief Financial Officer |
5 Former Executives
You’re viewing 2 of 7 executives. Get the full list »Medovex Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000000 0000000000 | Medovex | Board Member | 000 0000 | |
| 0000000 00000 | Medovex | Chief Executive Officer & Chairman | 000 0000 |
1 Former Board Member
You’re viewing 2 of 3 board members. Get the full list »